Inflammatory bowel disease is a spectrum of disorders whose etiology a
nd pathogenesis are unclear. No therapy is standard; many modalities e
xist for management. New drugs, improved formulations of existing drug
s, combination therapy, and biologic agents offer more effective relie
f and maintain disease remission.